Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

On the heels of a first quarter sales dip, leaders remain confident in Globus Medical’s full-year success, according to a May 8 earnings call. 1. Globus Medical’s Excelsius robotic technologies are ...

Joining today's call from Globus Medical will be Dan Scavilla, President and CEO, and Keith Pfeil, Chief Operating Officer and Chief Financial Officer. This review is being made available via webcast, ...

BTIG analyst Ryan Zimmerman lowered the firm’s price target on Globus Medical (GMED) to $77 from $88 and keeps a Buy rating on the shares. The ...

Discover key Q1 2025 insights from Globus Medical, including revenue trends, the Nevro acquisition, free cash flow growth, and future strategies.

Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion.

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

Globus Medical will hold a teleconference to discuss its first quarter 2025 results with the investment community at 4:30 p.m ...

As you can see from the chart above the percentage of shares that are sold short for Globus Medical has grown since its last report. This does not mean that the stock is going to fall in the near ...

Sioni Group and Isaac and Eli Chetrit finally secured a $275 million construction loan for their 70-story high-rise. The loan, secured this month from Intervest and Affinius Capital, allows the ...

as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Latest Health Care Equipment & Supplies ...